28.01.2025 15:38:16
|
Totus Medicines Appoints Simon Harnest As CFO
(RTTNews) - Totus Medicines, Developer of chemical biology technologies, Tuesday announced the appointment of Simon Harnest as Chief Financial Officer.
Simon with over 15 years in private capital markets strategy and IPO processes experience had served as Chief Investment Officer at Metagenomi Inc. (MGX)
The company said Harnest's appointment would help in the progress of corporate development strategy supporting TOS-358, the Company's lead covalent PI3Ka inhibitor, and additional programs.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Metagenomi Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Metagenomi Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Metagenomi Inc Registered Shs | 2,36 | -3,28% |
|